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ABSTRACT Arrestins are regulatory proteins that par-
ticipate in the termination of G protein-mediated signal
transduction. The major arrestin in the Drosophila visual
system, Arrestin 2 (Arr2), is phosphorylated in a light-
dependent manner by a Ca21ycalmodulin-dependent protein
kinase and has been shown to be essential for the termination
of the visual signaling cascade in vivo. Here, we report the
isolation of nine alleles of the Drosophila photoreceptor cell-
specific arr2 gene. Flies carrying each of these alleles under-
went light-dependent retinal degeneration and displayed elec-
trophysiological defects typical of previously identified arres-
tin mutants, including an allele encoding a protein that lacks
the major Ca21ycalmodulin-dependent protein kinase site.
The phosphorylation mutant had very low levels of phosphor-
ylation and lacked the light-dependent phosphorylation ob-
served with wild-type Arr2. Interestingly, we found that the
Arr2 phosphorylation mutant was still capable of binding to
rhodopsin; however, it was unable to release from membranes
once rhodopsin had converted back to its inactive form. This
finding suggests that phosphorylation of arrestin is necessary
for the release of arrestin from rhodopsin. We propose that the
sequestering of arrestin to membranes is a possible mecha-
nism for retinal disease associated with previously identified
rhodopsin alleles in humans.
G protein-coupled receptors are a large family of proteins that
have seven transmembrane domains and are activated in
response to a large variety of extracellular signals including
hormones, light, and odorants (1, 2). Receptor stimulation is
followed by the activation of a heterotrimeric G protein and
the subsequent activation of specific intracellular effector
molecules. Although a great deal of information has been
obtained concerning the activation of various G protein-
coupled signaling cascades, the mechanisms involved in inac-
tivating components of various cascades in vivo have not been
well established. To terminate signaling through the cascade
efficiently, all activated intermediates, including the receptor,
need to be inactivated.
The inactivation of G protein-coupled receptors, often
termed desensitization, has been studied most extensively for
rhodopsin and the b-adrenergic receptor (3–6). In both cases,
the molecular mechanism of desensitization occurs in a two-
step process. The first step involves a rapid phosphorylation of
the activated receptor by a specific G protein-coupled receptor
kinase (7, 8). Phosphorylation of receptors by G protein-
coupled receptor kinases results in only minimal desensitiza-
tion; however, phosphorylation does increase the affinity of
the receptors for another group of proteins, known as arrestins.
The binding of arrestin to the phosphorylated, activated
receptors quenches signal transduction via its apparent ability
to decrease receptoryG protein coupling directly (9–12).
Arrestin was identified originally as an abundant soluble
protein in the bovine retina and was called S antigen (13).
Subsequently, visual arrestin homologues have been identified
in a large number of species, and, in addition, numerous
arrestins have been found in nonretinal tissue. It has been
established that retinal and nonretinal arrestins mediate the
inactivation of G protein-coupled receptors, and this finding
has suggested a common mechanism for desensitizing this
large class of receptor molecules. In addition to its role in
inactivating receptor molecules, a subclass of arrestins also
have been shown to be involved in receptor-mediated endo-
cytosis (14, 15).
The Drosophila melanogaster visual system provides an
excellent model system for the study of G protein-coupled
receptor inactivation in vivo (16). The existence of numerous
mutations that affect phototransduction in Drosophila, along
with the ability to screen for additional mutations, allows for
a genetic dissection of this signaling pathway. Phototransduc-
tion in Drosophila is initiated by the activation of the G
protein-coupled receptor rhodopsin. Invertebrate rhodopsin
consists of the apoprotein, opsin, which is covalently linked to
an 11-cis-retinal chromophore. Photon absorption converts the
chromophore from the 11-cis conformation to all-trans with a
subsequent conformational change in the opsin moiety. Acti-
vated rhodopsin, or metarhodopsin, activates the alpha subunit
of a heterotrimeric G protein, which, in turn, activates an
eye-specific phospholipase C molecule. Phospholipase C hy-
drolyzes the membrane phospholipid phosphatidylinositol-4,5-
bisphosphate into two second messengers, inositol trisphos-
phate and diacylglycerol. Phospholipase C activity is required
to open two light-activated, cation-selective ion channels;
however, the molecular mechanism involved in the opening of
these channels has yet to be determined. Recent work has
implicated polyunsaturated fatty acids in gating both light-
activated channels (17).
In Drosophila, two visual system arrestins have been iden-
tified: Arr1 and Arr2. Whereas mutations in Arr1 have no
noticeable phenotype, severe loss-of-function mutations in
Arr2 undergo rapid light-dependent retinal degeneration and
are defective in rhodopsin inactivation (18, 19). Both Arr1 and
Arr2 are phosphorylated in a light-dependent manner, and it
has been established that Arr2 is phosphorylated by a Ca21y
calmodulin-dependent protein kinase (20). Although it has
been known for quite some time that Arr2 is phosphorylated
in a light-dependent manner, the role of this phosphorylation
is unknown. Here, we provide evidence that the phosphory-
lation of Arr2 is necessary for its release from membranes once
rhodopsin has been photoconverted back to its inactive form.
MATERIALS AND METHODS
Genetic Screen, Plasmid Construction, and Sequence Char-
acterization. arr2 mutants were generated by using a non-
complementation screen. Wild-type flies were treated with the
mutagen ethyl methanesulfonate and crossed to arr23 homozy-
gotes (18). arr23 heterozygotes undergo retinal degeneration in
room light in 8–10 days, so F1 flies were screened for enhanced
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked ‘‘advertisement’’ in
accordance with 18 U.S.C. §1734 solely to indicate this fact.
PNAS is available online at www.pnas.org.
This paper was submitted directly (Track II) to the Proceedings office.
*To whom reprint requests should be addressed. e-mail:
patrick.dolph@dartmouth.edu.
6072
retinal degeneration (at 3–5 days), indicated by the loss of a
deep pseudopupil (21). The S366A allele was generated by
using site-directed mutagenesis and introduced into the arr25
null background via P element-induced transposition (22, 23).
This construct contained '2 kilobases of endogenous pro-
moter sequence. For sequence analysis, the mutant arr2 genes
were isolated by PCR amplification of genomic DNA from the
mutant stocks. Two independent PCR fragments for each of
the mutant alleles were cloned into pBluescript II SK(1)
(Stratagene) and sequenced. Nucleotide sequences were ob-
tained on an Applied Biosystems model 373A Automated
Sequencer (Dartmouth College Molecular Biology Core Fa-
cility) by using the Ready-reaction Dye-Terminator kit with
AmpliTaq FS (Applied Biosystems).
Electroretinogram Analysis. Electroretinograms were per-
formed as described (18). Electrical signals were amplified
through a DAM50 amplifier (World Precision Instruments,
Sarasota, FL), digitized with a MacAdios ADPO (GW Instru-
ments, Somerville, MA), and viewed with SUPERSCOPE soft-
ware (GW Instruments). Stimulating light was generated with
a 300-W xenonymercury lamp (Oriel, Stamford, CT) and
attenuated through neutral density filters. Blue and orange
light was generated by filtering through 480 nm and 580 nm
band-pass filters (Oriel), respectively. All light pulses were 1 s
in duration and at maximum intensity except where noted. All
recordings were performed on newly eclosed adult f lies (less
than 2 days) that were reared in the dark.
Biochemical Assays. For Arr2 binding assays, 6–10 Drosoph-
ila heads were dissected from newly eclosed (less than 2 days)
dark-reared adults and added to a buffer containing 150 mM
KCl, 20 mM Tris (pH 7.5), 5 mM DTT, 10 mgyml PMSF, 0.5
mgyml leupeptin, 0.5 mgyml pepstatin, and 0.5 mgyml aproti-
nin. The heads were then exposed to 5 min of either orange
light (580 6 10 nm) or blue light (480 6 10 nm), homogenized
in the dark, and centrifuged at 13,000 3 g for 5 min. Pellet and
supernatant fractions were separated under very dim red light
and subjected to SDSyPAGE and Western analysis with
antibodies against Arr2 (18) and rhodopsin (Rh1; Develop-
mental Studies Hybridoma Bank, University of Iowa, Iowa
City). Arr2-release assays were performed in the same man-
ner, except that the isolated fly heads were exposed to 10 s of
blue light followed by 60 s of orange light.
In vitro phosphorylation assays were performed as described
(24). Briefly, 15 Drosophila heads from dark-reared newly
eclosed (less than 2 days) adults were dissected and homoge-
nized in 20 ml of the above-mentioned binding assay buffer.
Phosphorylation reactions were allowed to proceed for 10 min
and were assayed in 5 ml of 16 mM Tris (pH 7.5), 5 mM MgCl2,
5 mM b-mercaptoethanol, 10 mM ATP, 3 mCi [g-32P]ATP
(7,000 Ciymmol), and 1 ml of homogenate. The chelating
EGTA concentration was 2 mM, and calcium reactions con-
tained 0.5 mM CaCl2. For the in vitro phosphorylation reac-
tions (shown in Fig. 4), membranes were collected by centrif-
ugation at 13,000 3 g for 5 min, and the pellet and supernatant
fractions were separated and subjected to SDSyPAGE, auto-
radiography, and Western analysis with antibodies directed
against Arr1, Arr2, and Rh1.
For in vivo phosphorylation assays, newly eclosed (less than
two days) dark-reared flies that had been starved for 12 h were
fed [32P]orthophosphate for 24 h and then dark-adapted for
10 h (25, 26). Flies were then either brought into the light for
30 min or left in the dark, before being frozen in liquid nitrogen
and dehydrated in acetone. Retinas (n 5 15–20) were dissected
and homogenized in sample buffer containing the phosphatase
inhibitor okadaic acid (1 mgyml) and subjected to SDSyPAGE,
autoradiography, and Western analysis with antibodies di-
rected against Arr1, Arr2, and Rh1.
RESULTS
Genetic Screen for arr2 Alleles. To investigate the role of
Arr2 in Drosophila phototransduction further, we generated a
large collection of arr2 loss-of-function alleles. Based on the
observation that arr2 loss-of-function mutations undergo rapid
light-dependent retinal degeneration, a noncomplementation
screen was conducted to isolate additional arr2 mutations.
Wild-type males were treated with the mutagen ethyl meth-
anesulfonate and crossed to females homozygous for the arr23
loss-of-function mutation (18). The resulting F1 flies were
screened for enhanced retinal degeneration based on the
light-dependent loss of the deep pseudopupil (27, 28). In
screening over 150,000 chromosomes, eight previously uniden-
tified alleles of arr2 were found (Table 1). Sequence charac-
terization and immunoblot analysis indicated that six of these
alleles were either nonsense or missense mutations that failed
to produce detectable levels of Arr2 protein. To our knowl-
edge, apart from the nonsense mutations reported here, no
null mutations have been isolated in arrestin. The remaining
two arr2 alleles represent missense alleles that make between
30% and 45% of the wild-type levels of protein. All missense
alleles identified in the screen encode proteins with mutations
in highly conserved amino acids among known arrestins (Table
1). In addition, we have introduced into an arr2 null back-
ground a construct that alters a serine residue at position 366
to an alanine; this serine residue is known to be the major
light-dependent phosphorylation site in Arr2 (29).
Characterization of arr2 Alleles. Like the previously char-
acterized loss-of-function arr2 allele, the alleles described in
this study showed complete retinal degeneration based on
deep pseudopupil analysis after 3–4 days of light exposure.
None of the alleles showed any significant degeneration in the
dark, even after several weeks of exposure. Arrestin and
rhodopsin interact stoichiometrically; therefore, one might
assume that decreased levels of Arr2 would result in retinal
degeneration. Although the arr2 missense alleles generate less
Arr2 protein than wild type, this finding is not a significant
factor in the observed retinal degeneration. Arr2 heterozy-
gotes (50% of wild-type levels) require more than 10 days to
degenerate (P.G.A. and P.J.D., unpublished observations),
and all the missense alleles generated in the screen degenerate
in 3–4 days. Therefore, the degeneration in the missense alleles
is primarily due to the expression of a nonfunctional Arr2
protein rather than decreased levels of Arr2.
To examine further defects in the phosphorylation mutant
and other missense alleles found in the genetic screen, we
examined the electrophysiological responses of wild-type and
mutant flies by using electroretinogram recordings. An elec-
Table 1. arr2 alleles
Allele Protein level, % Amino acid change
arr24 ND Frameshift 1 deletion
arr25 ND Y20 3 stop
arr26 ND Q178 3 stop
arr27 ND Splice donor site mutation
arr28 ND V52 3 D*
arr29 ND L56 3 P*
arr210 30 6 8 P261 3 S*
arr211 45 6 8 D388 3 V*
arr2S366A† 21 6 7 S366 3 A
Protein levels are given in comparison to wild type (100%) and were
determined by quantifying band intensities on Western blots, using
Rh1 as a loading control. ND, not detectable by Western analysis. Data
are means 6 SD (n 5 5).
*These amino acids are highly conserved having between 88–68%
identity among 33 known arrestins.
†The S366A allele was generated by using site-directed mutagenesis
and was introduced into the arr25 null background via P element-
induced transposition.
Biochemistry: Alloway and Dolph Proc. Natl. Acad. Sci. USA 96 (1999) 6073
troretinogram recording represents the sum of the light-
induced electrical activity in the photoreceptor cells and their
downstream neurons. The photoreceptors of wild-type flies
depolarize in response to light and rapidly deactivate the
photoresponse once the light stimulus is terminated (Fig. 1A).
Consistent with previous work on an arr2 loss-of-function
allele (18), the arr2 null mutant (Y20STOP) had marked
electrophysiological defects in its inactivation kinetics, with an
increase in the time required to reach 85% inactivation (Fig.
1B). Flies carrying the three missense alleles, including the
S366A phosphorylation mutation, have deactivation kinetics
similar to those of flies carrying the arr2 null mutation. This
result indicates further that, although there is Arr2 protein
present in flies carrying all three missense alleles, it is essen-
tially nonfunctional.
Ser-366 Is the Sole Light-Induced Phosphorylation Site in
Arr2. The Arr2 missense allele that eliminates the serine at
position 366 provides a critical test of whether this residue is
the sole Ca21ycalmodulin-dependent protein kinase site in
Arr2. In lysates prepared from wild-type Drosophila heads,
Arr2 shows a high level of phosphorylation that depends on the
presence of calcium (Fig. 2A). However, Arr2 lacking the
phosphorylation site at position 366 fails to be phosphorylated
in vitro. A more stringent test for the presence and absence of
phosphorylation is to examine the phosphorylation of Arr2 in
vivo. For this in vivo test, f lies were labeled with 32P and either
exposed to light or kept in the dark; phosphoproteins were
then analyzed by PAGE. In wild-type flies, Arr2 is phosphor-
ylated in the light but has only low levels of Arr2 phosphor-
ylation in the dark (Fig. 2B). In contrast to wild type, the Arr2
S366A mutant fails to show light-induced phosphorylation.
Therefore, these data suggest that, both in vivo and in vitro, the
serine at position 366 represents the sole light-dependent
phosphorylation site in Arr2.
Visual system arrestins are known to bind the activated form
of rhodopsin (M form or metarhodopsin) and not to the
inactive form (R form; refs. 30 and 31). In Drosophila, rho-
dopsin can be photoconverted between the M and R forms in
response to the appropriate light stimulus (32). The major
rhodopsin in the Drosophila retina absorbs maximally at 480
nm (blue), converting the rhodopsin to the active M form, and
the M form can be photoconverted back to the inactive R form
with 580-nm light (orange; refs. 33 and 34). Because Arr2 is
known to bind to the M form, we wanted to test whether the
unphosphorylated form of Arr2 was defective in binding to the
M form. In wild-type flies, when rhodopsin is photoconverted
to the M form, Arr2 binds to membranes (Fig. 3A). However,
when wild-type flies are treated with orange light, thereby
generating the inactive R form of rhodopsin, the arrestin
remains largely cytoplasmic. Surprisingly, in spite of the fact
that flies carrying the arr2 phosphorylation mutation are
electrophysiologically indistinguishable from arr2 null alleles,
the Arr2 encoded by this allele shows the same degree of
binding to rhodopsin as does wild-type Arr2 (Fig. 3B). Clearly,
both wild-type and the unphosphorylated form of Arr2 are
interacting with rhodopsin, because the majority of Arr2 fails
to bind to membranes that lack the major rhodopsin, Rh1 (Fig.
3B). This result suggests that, although phosphorylation is
clearly essential for proper arrestin function, it is not required
for rhodopsin binding.
Arr2 Phosphorylation Is Necessary for Arr2 to Release from
Membranes. Because of the unexpected finding that the
FIG. 1. Flies carrying arr2 missense mutations have prolonged
deactivation kinetics that are indistinguishable from those of an arr2
null allele. (A) Representative electroretinogram recordings of white-
eyed control (w) and arr2 mutant flies exposed to a 1-s pulse of blue
light (480 nm). Electroretinograms were performed as described (18).
(B) Histogram of the time to 85% deactivation for white-eyed control
(w) and arr2 mutant flies. For w control f lies, t85 5 1.87 6 0.3 s; for
Y20STOP flies, t85 5 6.07 6 1.2 s; for S366A flies, t85 5 5.27 6 0.7 s;
for P261S flies, t85 5 5.05 6 0.5 s; for D388V flies, t85 5 5.03 6 0.5 s
(n 5 20–25). Data are means 6 SD.
FIG. 2. Phosphorylation assays of retinal proteins indicate that the
S366A mutant Arr2 protein is not phosphorylated in vitro and fails to
undergo light-induced phosphorylation in vivo. (A, Left) Autoradio-
graph of g-32P-labeled proteins isolated from Drosophila head lysates
in the presence of 0.5 mM Ca21 (lanes 1, 3, and 4) or 2 mM EGTA,
a calcium-specific chelator (lane 2). (A, Right) The same gel trans-
ferred to nitrocellulose and probed with antibodies specific for Arr1
and Arr2 (18), as well as Rh1 (Developmental Studies Hybridoma
Bank, University of Iowa). Y20STOP represents a null mutation in
Arr2. w, white-eyed control f lies. (B, Left) Autoradiographs of in vivo
g-32P-labeled retinal proteins from dark-reared white-eyed control (w)
and S366A flies either kept in the dark (D) or exposed to light for 30
min (L). (B, Right) The same gels transferred to nitrocellulose and
probed with antibodies specific for Arr2 and Arr1. Note the lack of
light-induced phosphorylation of Arr2 in the flies expressing the
S366A transgene.
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unphosphorylated form of Arr2 failed to show binding defects,
we reexamined the role of Arr2 phosphorylation and binding
to light-treated membranes. If phosphorylation of Arr2 is
essential for binding, the phosphorylated form of Arr2 would
be found associated with membranes, whereas the unphos-
phorylated form would be largely cytoplasmic. To test this
hypothesis, lysates from wild-type Drosophila heads were
incubated with [g-32P]ATP and then centrifuged to separate
the membrane and supernatant fractions. Once again, as
expected, Arr2 is phosphorylated in a calcium-dependent
manner (Fig. 4). The phosphorylated form of Arr2 is not
bound to membranes but, instead, is found as a soluble factor
in the supernatant, and the membrane bound form of arrestin
is completely unphosphorylated (Fig. 4). These results provide
additional evidence that phosphorylation of Arr2 is not nec-
essary for its binding to membranes when rhodopsin is pho-
toconverted to the active form.
Based on the above data, it is clear that phosphorylation of
Arr2 is not necessary for rhodopsin binding. Instead, we
propose that the phosphorylation mutant is defective in the
release of Arr2 from rhodopsin once rhodopsin is photocon-
verted to its inactive form. To test this idea, we took advantage
of the fact that invertebrate arrestin binds to metarhodopsin in
response to blue-light stimulus and is released when metarho-
dopsin is photoconverted back to its inactive R form with
orange light (30, 35). As expected, the Arr2 protein in wild-
type flies binds to rhodopsin under blue-light conditions, and
70–80% is released after subsequent exposure to orange light
(Fig. 5). However, although the mutant S366A Arr2 protein
binds to the activated form of rhodopsin, Arr2 fails to release
from rhodopsin after orange-light treatment (Fig. 5), suggest-
ing that Arr2 phosphorylation is necessary for arrestin to
release from rhodopsin.
If the role of Arr2 phosphorylation is to allow its release
from rhodopsin, then second site mutations that show de-
creased levels of arrestin phosphorylation should also show
defects in release. It has been shown previously that flies with
mutations in the eye-specific phospholipase C (norpA; refs. 29
and 36) and calmodulin (cam; ref. 37) have low levels of Arr2
phosphorylation. As can be seen in Fig. 5, norpA and cam
mutants still show Arr2 membrane binding that is identical to
wild type. Again, this result indicates that Arr2 phosphoryla-
tion does not play a role in rhodopsin binding, and all that is
required for Arr2 binding is rhodopsin activation. However,
after orange-light stimulus, norpA mutants fail to release Arr2,
and cam mutants release ,50% of the Arr2 (compared with
70–80% for wild type). The portion of Arr2 that does release
in cam mutants can be accounted for by the low levels of Arr2
phosphorylation that has been observed in this genetic back-
ground (37).
Further evidence supporting this model comes from the two
missense alleles, P261S and D388V. Although these two
mutations do not alter the Ca21yCam dependent protein
kinase site directly, both missense alleles fail to show any
significant phosphorylation of Arr2 in vitro. (Fig. 6A). It is
possible that the mutations generate a structurally altered Arr2
molecule that cannot serve as a substrate for the kinase. In
addition, these two missense alleles show no defects in rho-
dopsin binding; however, biochemical analysis of these two
mutants indicates that, like the phosphorylation mutant, they
generate Arr2 proteins that are unable to release from rho-
dopsin (Fig. 6B). Taken together, these data suggest that in the
absence of phosphorylation, the arrestin cycle is disrupted;
membrane translocation of Arr2 is unaltered, but its subse-
quent release from rhodopsin is inhibited.
DISCUSSION
Although it has been known for quite some time that Arr2 is
phosphorylated in a light-dependent manner (25), it is unclear
just what role this phosphorylation serves. The invertebrate
phototransduction cascade results in an increase in intracel-
lular calcium. It has been proposed that the calcium- and
light-dependent phosphorylation of Arr2 acts as the signal to
bind and inactivate metarhodopsin, and, therefore, Arr2 phos-
phorylation serves to modulate the inactivation of the signaling
cascade (20, 30, 38, 39). However, we have found that arrestin
is able to bind to activated rhodopsin in the absence of
phosphorylation, arguing against this feedback-regulation
model. Invertebrate Arr2 is a very basic molecule with a pKa
of '8.7 (31). This characteristic may allow it to rapidly interact
with an exposed acidic surface on activated rhodopsin in the
absence of any covalent modification. Instead, posttransla-
tional modification is required to remove arrestin from rho-
dopsin. Phosphorylation of Arr2 when it is bound to rhodopsin
may trigger a conformational change or add negative charge
that enables the release of Arr2.
FIG. 3. S366A flies retain the ability to bind to rhodopsin in a
light-dependent manner. (A) Isolated wild-type fly heads were ex-
posed to 5 min of either orange (580 nm) or blue (480 nm) light,
homogenized in the dark, and centrifuged (13,000 3 g for 5 min) Pellet
(P) and supernatant (S) fractions were subjected to SDSyPAGE and
Western analysis with antibodies directed against Arr2 and Rh1. (B)
Western blot of white-eyed control (w), ninaEI17, S366A, and
S366A;ninaEI17 heads that were exposed to 5 min of blue light and then
fractionated and centrifuged as described in A. ninaEI17 represents a
null mutation in the structural gene for the major rhodopsin, Rh1
FIG. 4. Phosphorylated Arr2 protein is found as a non-membrane-
associated soluble factor. (Left) Autoradiograph of g-32P-labeled
proteins isolated from fractionated wild-type Drosophila head lysates
in the presence of 0.5 mM Ca21 (lanes 1 and 2) or 2 mM EGTA (lanes
3 and 4). S, supernatant fraction; P, pellet fraction. (Right) The same
gel transferred to nitrocellulose and probed with antibodies specific for
Arr1, Arr2, and Rh1.
Biochemistry: Alloway and Dolph Proc. Natl. Acad. Sci. USA 96 (1999) 6075
The finding that the phosphorylation of Arr2 is required for
proper function brings up an apparent discrepancy: previously,
the C terminus of Arr2 was determined to be nonessential (18).
In the previous study, a truncated form of Arr2 that lacked the
last 45 aa of Arr2, including the serine at position 366, was
generated; this mutated form of Arr2 was phenotypically
normal. An identical situation occurs in the bovine system,
where deletion of the C terminus of arrestin yields a protein
that still binds to rhodopsin but has lost its binding specificity,
binding to both photoactivated and nonphotoactivated rho-
dopsin (40). As such, we believe that the truncated form of
Arr2 is not defective in release from rhodopsin but instead
binds indiscriminately to both the active and inactive forms of
rhodopsin. The truncation mutant is phenotypically normal, as
it still has a higher binding affinity for the active form of
rhodopsin.
In the missense alleles generated from the screen, Arr2 is
found associated with membranes under all light conditions.
This finding clearly explains the null phenotype of these alleles.
Because rhodopsin is approximately five times more abundant
than arrestin (18), all of the Arr2 becomes bound to mem-
branes, and no soluble Arr2 is available to bind and inactivate
metarhodopsin. However, it is unclear whether the titration of
arrestin or the formation of arrestinyrhodopsin complexes is
the primary cause of retinal degeneration in these alleles.
Interestingly, many recently characterized human dominant
rhodopsin alleles that are associated with retinitis pigmentosa
and stationary night blindness also have defects in arrestin
binding (41, 42). These alleles show continuous activity of
rhodopsin in vitro; however, both in vitro and in vivo, these
aberrant rhodopsin proteins are constitutively bound to arres-
tin. One possible mechanism for retinal degeneration in these
dominant alleles is the titration of arrestin caused by its
increased affinity for the aberrant rhodopsin proteins. In this
way, photoreceptor cells undergo degeneration because of
insufficient levels of soluble arrestin to quench newly formed
metarhodopsin.
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FIG. 6. The P261S and D388V missense Arr2 proteins are not
phosphorylated in vitro and have defects in releasing from rhodopsin.
(A, Left) Autoradiograph of g-32P-labeled proteins isolated from
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same gel transferred to nitrocellulose and probed with antibodies
specific for Arr2. P261S and D388V represent missense mutations in
Arr2. w, white-eyed control f lies. (B) Western blot of fractionated
P261S and D388V mutant heads that were exposed to 10 s of blue light
(B) or 10 s of blue light followed by 60 s of orange light (BO). Pellet
(P) and supernatant (S) fractions were subjected to SDSyPAGE and
Western analysis with antibodies directed against Arr2 and Rh1.
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